Author: Saba Kash

Singaporean man dies after massage in Phuket; safety concerns arise from two recent massage-related deaths in Thailand.

Thai silk is entering medicine’s future. Scientists harness silk fibroin, a protein from silkworms, to create advanced drug delivery systems. This innovation not only offers safer treatments but also revitalises Thailand’s silk industry with modern purpose.

A health screening connects the dots between your lifestyle and wellness, uncovering silent changes. The year-end is your chance to catch small issues, set goals, and start the New Year with actionable insights for better health.

From sunburn to altitude sickness, travel comes with unexpected risks. A well-stocked first aid kit ensures you’re ready for minor mishaps, letting you focus on enjoying your holiday. Here’s what to pack for safe, stress-free adventures wherever you go.

Singapore’s MOH bans prescription weight-loss drug ads by telehealth companies over misleading claims. Authorities warn these ads may bypass regulations and harm vulnerable individuals. Here’s how to spot red flags and make safer health choices.

The festive season is for joy and togetherness, but even good times can strain your heart. From Happy Heart Syndrome to overindulging at parties, learn how to balance celebration with self-care so you can enjoy the holidays to the fullest – safely and happily!

A participant tragically passed away after completing the Standard Chartered Singapore Marathon 2024 on Dec 1. Despite immediate medical aid and transport to a hospital, the runner did not survive. This marks the third death in the marathon’s history since its inception in 2002.

The World Needs Science, and Science Needs Women. Recognised at the 2024 L’Oréal-UNESCO For Women in Science awards, these female Singaporean scientists are inspiring the next generation of diverse innovators.

Singapore’s BRAVE study, led by the Institute of Mental Health, invites up to 40,000 families to screen children aged 8–18 for ADHD, autism, and depression. Participants flagged at risk receive free diagnostic tests and guidance on follow-up care.

Novo Nordisk launches Wegovy in China, targeting the country’s 180 million people with obesity. Priced at ¥1,400 ($192 USD) per starter dose, it faces accessibility challenges as it’s not covered by national insurance. The move heightens competition with Eli Lilly.